Identification of novel biomarkers for frailty diagnosis via serum amino acids metabolomic analysis using UPLC‐MS/MS
PROTEOMICS – Clinical Applications · 2024-05 · 18 (3)
DOI: 10.1002/prca.202300035 ↗Kurz gefasst
Fachartikel in der Zeitschrift PROTEOMICS – Clinical Applications, online erschienen am 09.01.2024. Verfasst von Mengyuan Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Clinical Laboratory, Zhejiang Hospital, Hangzhou, P. R. China. Hauptthemen laut MEDLINE: Amino Acids, Tandem Mass Spectrometry, Biomarkers, Metabolomics. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Zhejiang Provincial basic public welfare research project.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Purpose
This study was aimed to analyze serum amino acid metabolite profiles in frailty patients, gain a better understanding of the metabolic mechanisms in frailty, and assess the diagnostic value of metabolomics‐based biomarkers of frailty. Experimental Design This study utilized the ultra‐performance liquid chromatography tandem mass spectrometry to examine amino acids associated with frailty. Additionally, we employed multivariate statistical methods, metabolomic data analysis, receiver operating characteristic (ROC) curve analysis, and pathway enrichment analysis.
Results
Among the assayed amino acid metabolites, we identified biomarkers for frailty. ROC curve analysis for frailty diagnosis based on the modified Fried's frailty index showed that the areas under ROC curve of tryptophan, phenylalanine, aspartic acid, and combination were 0.775, 0.679, 0.667, and 0.807, respectively. ROC curve analysis for frailty diagnosis based on Frail Scale showed that the areas under ROC curve of cystine, phenylalanine, and combination of amino acids (cystine, L‐Glutamine, citrulline, tyrosine, kynurenine, phenylalanine, glutamin acid) were 0.834, 0.708, and 0.854 respectively. Conclusion and Clinical Relevance In this study, we explored the serum amino acid metabolite profiles in frailty patients. These present metabolic analyses may provide valuable information on the potential biomarkers and the possible pathogenic mechanisms of frailty. Clinical Significance Frailty is a clinical syndrome, as a consequence it is challenging to identify at early course of the disease, even based on the existing frailty scales. Early diagnosis and appropriate patient management are the key to improve the survival and limit disabilities in frailty patients. Proven by the extensive laboratory and clinical studies on frailty, comprehensive analysis of metabolic levels in frail patients, identification of biomarkers and study of pathogenic pathways of metabolites contribute to the prediction and early diagnosis of frailty. In this study, we explored the serum amino acid metabolite profiles in frailty patients. These present metabolic analyses may provide valuable information on the potential biomarkers and the possible pathogenic mechanisms of frailty.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Department of Clinical Laboratory, Zhejiang Hospital, Hangzhou, P. R. China.
- The Department of Geriatrics, Zhejiang Hospital, Hangzhou, P. R. China.
- School of Laboratory Medicine, Wenzhou Medical University, Wenzhou, P. R. China.
ORCID-Profile: Meng Li
Förderung
- Zhejiang Provincial basic public welfare research project
Zitieren
APA
Zhou, M., Sun, W., Chu, J., Liao, Y., Xu, P., Chen, X., & Li, M. (2024). Identification of novel biomarkers for frailty diagnosis via serum amino acids metabolomic analysis using UPLC‐MS/MS. PROTEOMICS – Clinical Applications, 18(3). https://doi.org/10.1002/prca.202300035
Vancouver
Zhou M, Sun W, Chu J, Liao Y, Xu P, Chen X, et al. Identification of novel biomarkers for frailty diagnosis via serum amino acids metabolomic analysis using UPLC‐MS/MS. PROTEOMICS – Clinical Applications. 2024;18(3). doi:10.1002/prca.202300035
BibTeX
@article{Zhou2024,
author = {Zhou, Mengyuan and Sun, Wenjing and Chu, Jiaojiao and Liao, Yingping and Xu, Pengfei and Chen, Xujiao and Li, Meng},
title = {Identification of novel biomarkers for frailty diagnosis via serum amino acids metabolomic analysis using UPLC‐MS/MS},
journal = {PROTEOMICS – Clinical Applications},
year = {2024},
volume = {18},
number = {3},
doi = {10.1002/prca.202300035}
}
EUVIMED